Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The Western Africa ebola virus disease epidemic exhibits both global exponential and local polynomial growth ratesPLoS currents, 2015-01, Vol.7ISSN: 2157-3999 ;EISSN: 2157-3999 ;DOI: 10.1371/currents.outbreaks.8b55f4bad99ac5c5db3663e916803261 ;PMID: 25685633Full text available |
|
2 |
Material Type: Article
|
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trialThe Lancet infectious diseases, 2021-04, Vol.21 (4), p.493-506 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30476-X ;PMID: 33217361Full text available |
|
3 |
Material Type: Article
|
Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against EbolaEmerging infectious diseases, 2020-03, Vol.26 (3), p.541-548 [Peer Reviewed Journal]Published 2020. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2603.191018 ;PMID: 32017677Full text available |
|
4 |
Material Type: Article
|
Phase 1 Trials of rVSV Ebola Vaccine in Africa and EuropeThe New England journal of medicine, 2016-04, Vol.374 (17), p.1647-1660 [Peer Reviewed Journal]Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1502924 ;PMID: 25830326Full text available |
|
5 |
Material Type: Article
|
Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the CongoNature Medicine, 2021-04, Vol.27 (4), p.710-716 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1078-8956 ;EISSN: 1546-170X ;EISSN: 1744-7933 ;DOI: 10.1038/s41591-021-01302-z ;PMID: 33846610Full text available |
|
6 |
Material Type: Article
|
Services for mothers and newborns during the ebola outbreak in liberia: the need for improvement in emergenciesPLoS currents, 2015-04, Vol.7ISSN: 2157-3999 ;EISSN: 2157-3999 ;DOI: 10.1371/currents.outbreaks.4ba318308719ac86fbef91f8e56cb66f ;PMID: 25932347Full text available |
|
7 |
Material Type: Article
|
Whole Genome Sequence Analysis of Salmonella Enteritidis PT4 Outbreaks from a National Reference Laboratory's ViewpointPLoS currents, 2015-09, Vol.7ISSN: 2157-3999 ;EISSN: 2157-3999 ;DOI: 10.1371/currents.outbreaks.aa5372d90826e6cb0136ff66bb7a62fc ;PMID: 26468422Full text available |
|
8 |
Material Type: Article
|
Media Messages and Perception of Risk for Ebola Virus Infection, United StatesEmerging infectious diseases, 2017-01, Vol.23 (1), p.108-111 [Peer Reviewed Journal]COPYRIGHT 2017 U.S. National Center for Infectious Diseases ;COPYRIGHT 2017 U.S. National Center for Infectious Diseases ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2301.160589 ;PMID: 27983495Full text available |
|
9 |
Material Type: Article
|
Effect of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the CongoEmerging infectious diseases, 2022-06, Vol.28 (6), p.1180-1188 [Peer Reviewed Journal]COPYRIGHT 2022 U.S. National Center for Infectious Diseases ;Published 2022. This article is a U.S. Government work and is in the public domain in the USA. ;2022 ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2806.212223 ;PMID: 35608607Full text available |
|
10 |
Material Type: Article
|
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOVNature medicine, 2019-10, Vol.25 (10), p.1589-1600 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2019 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-019-0602-4 ;PMID: 31591605Full text available |
|
11 |
Material Type: Article
|
Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virusNature (London), 2015-04, Vol.520 (7549), p.688-691 [Peer Reviewed Journal]COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Apr 30, 2015 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature14428 ;PMID: 25853476 ;CODEN: NATUASFull text available |
|
12 |
Material Type: Article
|
Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical TrialPLoS medicine, 2016-04, Vol.13 (4), p.e1001997 [Peer Reviewed Journal]COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Dunning J, Sahr F, Rojek A, Gannon F, Carson G, Idriss B, et al. (2016) Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial. PLoS Med 13(4): e1001997. doi:10.1371/journal.pmed.1001997 ;2016 Dunning et al 2016 Dunning et al ;2016 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Dunning J, Sahr F, Rojek A, Gannon F, Carson G, Idriss B, et al. (2016) Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial. PLoS Med 13(4): e1001997. doi:10.1371/journal.pmed.1001997 ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1001997 ;PMID: 27093560Full text available |
|
13 |
Material Type: Article
|
The Ebola outbreak, 2013–2016: old lessons for new epidemicsPhilosophical transactions of the Royal Society of London. Series B. Biological sciences, 2017-05, Vol.372 (1721), p.20160297-20160297 [Peer Reviewed Journal]2017 The Authors. ;Copyright The Royal Society Publishing May 26, 2017 ;2017 The Authors. 2017 ;ISSN: 0962-8436 ;EISSN: 1471-2970 ;DOI: 10.1098/rstb.2016.0297 ;PMID: 28396469Full text available |
|
14 |
Material Type: Article
|
Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primatesNature (London), 2015-05, Vol.521 (7552), p.362-365 [Peer Reviewed Journal]COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group May 21, 2015 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature14442 ;PMID: 25901685 ;CODEN: NATUASFull text available |
|
15 |
Material Type: Article
|
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg virusesThe Journal of pathology, 2015-01, Vol.235 (2), p.153-174 [Peer Reviewed Journal]Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd ;Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. ;Copyright © 2015 Pathological Society of Great Britain and Ireland ;ISSN: 0022-3417 ;EISSN: 1096-9896 ;DOI: 10.1002/path.4456 ;PMID: 25297522Full text available |
|
16 |
Material Type: Article
|
Reversion of advanced Ebola virus disease in nonhuman primates with ZMappNature (London), 2014-10, Vol.514 (7520), p.47-53 [Peer Reviewed Journal]COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2, 2014 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature13777 ;PMID: 25171469 ;CODEN: NATUASFull text available |
|
17 |
Material Type: Article
|
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challengeNature medicine, 2014-10, Vol.20 (10), p.1126-1129 [Peer Reviewed Journal]COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Oct 2014 ;Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2014. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/nm.3702 ;PMID: 25194571Full text available |
|
18 |
Material Type: Article
|
Ebola haemorrhagic feverThe Lancet (British edition), 2011-03, Vol.377 (9768), p.849-862 [Peer Reviewed Journal]Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;2011. Elsevier Ltd ;Copyright Elsevier Limited Mar 5-Mar 11, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60667-8 ;PMID: 21084112 ;CODEN: LANCAOFull text available |
|
19 |
Material Type: Article
|
Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus DiseaseThe New England journal of medicine, 2021-04, Vol.384 (13), p.1240-1247 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2024670 ;PMID: 33789012Full text available |
|
20 |
Material Type: Article
|
A Recombinant Vesicular Stomatitis Virus Ebola VaccineThe New England journal of medicine, 2017-01, Vol.376 (4), p.330-341 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1414216 ;PMID: 25830322Full text available |